Reassurance for parents: How safe are the 2019 strains of influenza vaccine?

31 May 2019

AusVaxSafety is an active vaccine safety surveillance system that monitors the safety of vaccines in Australia, facilitating early detection of potential vaccine safety issues.

Since 1 April 2019, monitoring of the safety of the 2019 influenza vaccines in all ages commenced, and more than 30,000 participants have provided feedback via SMS after their jab.

26 May 2019 data for influenza vaccine in children <3years

In the days following vaccination, responses are solicited via an automated SMS or email sent using SmartVax or Vaxtracker. More than 300 sites across Australia (78 in NSW) have implemented these tools, including general practices, hospitals, schools, community clinics and Aboriginal Medical Services.

SmartVax software is FREE for practices and is compatible with Medical Director, Best Practice, Zedmed, ImPS, PractiX, MedTech and WINVaccs. It is fully automated and runs in the background, requiring no interaction.

Smartvax provides participant reports of adverse events following immunisation to the AusVaxSafety active vaccine safety surveillance system coordinated by NCIRS to monitor vaccine safety and reassure parents and providers.

AusVaxSafety has also completed detailed vaccine safety analyses of all National Immunisation Program (NIP) vaccines using SmartVax data. The Vaccine safety in Australia AusVaxSafety summary report 2016–17 shows how parents and carers responded to an SMS about their child's health a few days after their vaccination at each schedule point in the NIP. 115,970 vaccination encounters were included in the analysis and the results confirm that vaccines on the NIP are safe.

Further information: